Freedom Broker Downgrades Mosaic to Sell, Raises Target to $18
The firm's new $18.00 price target compares with $17.00 before the change, and Mosaic's coverage is now mostly neutral.
Key points
- Freedom Broker downgraded Mosaic to sell from hold and raised its target to $18.00 from $17.00
- Mosaic closed at $22.80 on Wednesday, down 0.8%; the S&P 500 ETF rose 1.3%
- Before the change, 15 firms covered the stock: four positive, 10 neutral, one negative
- Median target before the change was $22.50, range $17.00 to $33.00
Freedom Broker downgraded Mosaic Co (NYSE: MOS) to sell from hold on Wednesday and raised its price target to $18.00 from $17.00. The action came during the session.
Before the change, 15 firms had rated Mosaic in the past year: four positive, 10 neutral and one negative. Freedom Broker's move shifts its own rating from neutral to negative, and the median target across the 14 firms with a target was $22.50 before Wednesday, with a range from $17.00 to $33.00.
Stock move
Mosaic closed at $22.80 on Wednesday, down 0.8% from $22.99 at the close on Tuesday, Nov. 10. The S&P 500 ETF rose 1.3% in the same session. Over the 20 sessions through Tuesday's close, the stock had risen 19.9%.
Recent financials
For the latest reported quarter ended Sept. 30, Mosaic posted revenue of $3.10 billion, down 10% from a year earlier, and a net loss of $72.1 million, or a loss of $0.23 per diluted share. The company reported cash and equivalents of $272.6 million as of the same date. Its market capitalization before the filing was about $7.31 billion.
Mosaic filed a quarterly report on Form 10-Q on Wednesday, Nov. 4, seven days before the downgrade (SEC filing).
Sources
Written with AI from analyst rating changes, SEC filings and market data, and checked against those sources before publishing. Our editorial standards.
More analyst ratings
- Keefe, Bruyette & Woods Downgrades Redwood Trust to Market Perform, Cuts Target to $3.50 · RWT · Nov. 12, 2026
- JPMorgan Upgrades Mercury Systems to Overweight, Cuts Target to $102 · MRCY · Nov. 11, 2026
- Keybanc Upgrades Maravai Lifesciences to Overweight, Sets $11.00 Target · MRVI · Nov. 12, 2026
- Five Analysts Downgrade Nvidia, Cut Targets at Three Firms · NVDA · Nov. 12, 2026
More on Mosaic
MOS page →Filings, figures and price history are on the Mosaic page.